TERMINATION AND ACCELERATION OF VENTRICULAR-TACHYCARDIA WITH AUTODECREMENTAL PACING, BURST PACING, AND CARDIOVERSION IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR

被引:35
作者
HAMMILL, SC [1 ]
PACKER, DL [1 ]
STANTON, MS [1 ]
FETTER, J [1 ]
BARDY, G [1 ]
BENDITT, D [1 ]
BREITHARDT, G [1 ]
CAMM, AJ [1 ]
COUMEL, P [1 ]
DENDULK, K [1 ]
DUBUC, M [1 ]
ECHT, D [1 ]
HAMMILL, S [1 ]
KERR, C [1 ]
KLEIN, G [1 ]
KUCK, KH [1 ]
MILES, W [1 ]
PORTERFIELD, J [1 ]
RUSKIN, J [1 ]
STEINHAUS, D [1 ]
TOUBOUL, P [1 ]
TROUP, P [1 ]
WELLENS, HJJ [1 ]
WHEELAN, K [1 ]
机构
[1] MEDTRONIC INC,MINNEAPOLIS,MN
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1995年 / 18卷 / 01期
关键词
ANTITACHYCARDIA PACING; VENTRICULAR ARRHYTHMIAS;
D O I
10.1111/j.1540-8159.1995.tb02469.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This multicenter study reports the outcome of ventricular tachycardia (VT) therapy (conversion or acceleration) and the relationship to initial tachycardia cycle length and other clinical variables using an implantable device with the capability of autodecremental or burst pacing, cardioversion, and defibrillation. The device was implanted in 444 patients (mean age 58 +/- 15 years) with 1,240 episodes of VT induced with noninvasive programming and reported in a multicenter database. Only the first sequence attempted for conversion by pacing or cardioversion was assessed, and cardioversion energies were 0.2-5 J. Autodecremental pacing was used to treat 700 induced episodes of VT during titration of pacing therapies (57% converted and 12% accelerated), burst pacing to treat 357 episodes (49% converted and 11% accelerated), and cardioversion to treat 183 episodes (82% converted and 4% accelerated). Cardioversion was the most effective treatment and had the lowest acceleration rate. Shorter VT cycle lengths were more likely to accelerate with burst pacing and longer VT cycle lengths to convert with both burst and autodecremental pacing. Patients with higher ejection fractions were more likely to convert with autodecremental and burst pacing. Use of cardioversion, higher ejection fraction, absence of unrepaired aneurysm, longer VT cycle lengths, coronary artery disease, and use of autodecremental pacing predicted conversion. Lower ejection fraction and VT cycle lengths less than or equal to 300 msec predicted tachycardia acceleration.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 21 条
[1]   CLINICAL-EXPERIENCE WITH A TIERED-THERAPY, MULTIPROGRAMMABLE ANTIARRHYTHMIA DEVICE [J].
BARDY, GH ;
TROUTMAN, C ;
POOLE, JE ;
KUDENCHUK, PJ ;
DOLACK, GL ;
JOHNSON, G ;
HOFER, B .
CIRCULATION, 1992, 85 (05) :1689-1698
[2]   A PROSPECTIVE RANDOMIZED REPEAT-CROSSOVER COMPARISON OF ANTITACHYCARDIA PACING WITH LOW-ENERGY CARDIOVERSION [J].
BARDY, GH ;
POOLE, JE ;
KUDENCHUK, PJ ;
DOLACK, GL ;
KELSO, D ;
MITCHELL, R .
CIRCULATION, 1993, 87 (06) :1889-1896
[3]   A THEORETICALLY AND PRACTICALLY MORE EFFECTIVE METHOD FOR INTERRUPTION OF VENTRICULAR-TACHYCARDIA - SELF-ADAPTING AUTODECREMENTAL OVERDRIVE PACING [J].
CHAROS, GS ;
HAFFAJEE, CI ;
GOLD, RL ;
BISHOP, RL ;
BERKOVITS, BV ;
ALPERT, JS .
CIRCULATION, 1986, 73 (02) :309-315
[4]   A PROSPECTIVE RANDOMIZED STUDY OF THE CLINICAL EFFICACY AND SAFETY OF TRANSVENOUS CARDIOVERSION FOR TERMINATION OF VENTRICULAR-TACHYCARDIA [J].
CICCONE, JM ;
SAKSENA, S ;
SHAH, Y ;
PANTOPOULOS, D .
CIRCULATION, 1985, 71 (03) :571-578
[5]   COMPARISON OF DECREMENTAL AND BURST OVERDRIVE PACING AS TREATMENT FOR VENTRICULAR-TACHYCARDIA ASSOCIATED WITH CORONARY-ARTERY DISEASE [J].
COOK, JR ;
KIRCHHOFFER, JB ;
FITZGERALD, TF ;
LAJZER, DA .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (03) :311-315
[6]   TERMINATION OF VENTRICULAR TACHYCARDIA WITH BURSTS OF RAPID VENTRICULAR PACING [J].
FISHER, JD ;
MEHRA, R ;
FURMAN, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (01) :94-102
[7]   EFFICACY OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IN PROLONGING SURVIVAL IN PATIENTS WITH SEVERE UNDERLYING CARDIAC DISEASE [J].
FOGOROS, RN ;
ELSON, JJ ;
BONNET, CA ;
FIEDLER, SB ;
BURKHOLDER, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (02) :381-386
[8]   EFFICACY OF AUTOMATIC MULTIMODAL DEVICE THERAPY FOR VENTRICULAR TACHYARRHYTHMIAS AS DELIVERED BY A NEW IMPLANTABLE PACING CARDIOVERTER-DEFIBRILLATOR - RESULTS OF A EUROPEAN MULTICENTER STUDY OF 102 IMPLANTS [J].
FROMER, M ;
BRACHMANN, J ;
BLOCK, M ;
SIEBELS, J ;
HOFFMANN, E ;
ALMENDRAL, J ;
OHM, OJ ;
DENDULK, K ;
COUMEL, P ;
CAMM, AJ ;
TOUBOUL, P .
CIRCULATION, 1992, 86 (02) :363-374
[9]   THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AS ANTIARRHYTHMIC TREATMENT MODALITY OF CHOICE FOR SURVIVORS OF CARDIAC-ARREST UNRELATED TO ACUTE MYOCARDIAL-INFARCTION [J].
LEHMANN, MH ;
STEINMAN, RT ;
SCHUGER, CD ;
JACKSON, K .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (10) :803-805
[10]   REDUCTION IN DEFIBRILLATOR SHOCKS WITH AN IMPLANTABLE DEVICE COMBINING ANTITACHYCARDIA PACING AND SHOCK THERAPY [J].
LEITCH, JW ;
GILLIS, AM ;
WYSE, DG ;
YEE, R ;
KLEIN, GJ ;
GUIRAUDON, G ;
SHELDON, RS ;
DUFF, HJ ;
KIESER, TM ;
MITCHELL, LB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (01) :145-151